BD forms Sustainable Medical Technology Institute to reduce environmental impact of its product portfolio

BD, also known as Becton, Dickinson and Co., formed a Sustainable Medical Technology Institute to focus on reducing the environmental impact of the company’s product portfolio in three areas, including adopting sustainable product design strategies, developing and deploying sustainable sterilization technologies, and addressing materials of concern.

The Franklin Lakes-based medical device maker said the institute will drive sustainable innovation in three areas of environmental stewardship, furthering progress toward the company’s 2030+ environmental, social and governance commitments.

“As part of our ESG strategy, we made commitments in specific areas where we see the most opportunity for BD to create meaningful, measurable change over the next decade,” said Maureen Mazurek, vice president, sustainability and environmental health and safety, at BD.

The institute will operate in North America, Europe and Asia, and will collaborate with crossfunctional teams within the company’s business units.

Dr. Amit Limaye, director of the Sustainable Medical Technology Institute and director of sustainability research and development at BD, added: “By empowering our teams to tap into deep expertise in areas like engineering and materials science, coupled with access to breakthrough research, technologies, and government and academic partnerships, we are well-positioned to be the best environmental stewards of our portfolio. It is our vision to create a strategic roadmap that will be integral across the organization, demonstrating how an ethical and sustainable company can drive growth, while meeting patient and customer needs in the most environmentally sustainable way possible.”